Related Experiment Video
Updated: Aug 3, 2025

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
Published on: December 9, 2016
Ewing sarcoma treatment: a gene therapy approach
Sergey Tsibulnikov1, Daria Fayzullina1, Irina Karlina1
1Group of Experimental Biotherapy and Diagnostics, Institute for Regenerative Medicine, World-Class Research Centre "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow State Medical University, Moscow, 119991, Russia.
Abstract:
Ewing sarcoma (ES) is an aggressive malignant tumor, characterized by non-random chromosomal translocations that produce fusion genes. Fusion genes and fusion protein products are promising targets for gene therapy. Therapeutic approaches and strategies vary based on target molecules (nucleotides, proteins) of interest. We present an extensive literature review of active molecules for gene therapy and methods of gene therapy delivery, both of which are necessary for successful treatment.
Insights
Ewing sarcoma (ES) is an aggressive cancer. Gene therapy targeting fusion genes offers promising treatment strategies by focusing on specific molecules and delivery methods.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ewing sarcoma (ES) is a highly aggressive cancer.
- ES is characterized by specific chromosomal translocations creating fusion genes.
- Fusion genes and their protein products are key drivers of ES development.
Purpose of the Study:
- To review active molecules for gene therapy in ES.
- To explore various gene therapy delivery methods for ES treatment.
- To provide a comprehensive overview of current gene therapy strategies for ES.
Main Methods:
- Extensive literature review.
- Analysis of scientific publications on ES gene therapy.
- Synthesis of information on therapeutic targets and delivery systems.
Main Results:
- Identified numerous active molecules (nucleotides, proteins) as potential gene therapy targets.
- Detailed various gene therapy delivery methods suitable for ES.
- Highlighted the necessity of both target molecule selection and effective delivery for successful treatment.
Conclusions:
- Fusion genes in ES are viable targets for gene therapy.
- Successful ES gene therapy requires careful selection of therapeutic molecules and efficient delivery strategies.
- Further research into targeted gene therapies holds significant promise for treating Ewing sarcoma.
More Related Videos
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
07:31A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle
Gene Therapy
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...